a complete vascular wall. 13, 70 Among the general population, the reported prevalence of CNS cavernous malformations is 0.4%-0.6%. 16, 25, 31, 48, 52, 56 These lesions most often occupy the intracranial (mainly supratentorial) compartment. 10, 16, 25, 33, 52, 66 By contrast, spinal cord cavernous malformations are very rare entities, accounting for 5%-12% of intraspinal vascular malformations. 14, 24, 29 In comparison with cavernous malformations within the cerebral hemispheres, those involving the spinal cord are thought to result in poorer outcomes. 10, 33 Historically, cases of intramedullary spinal cord cavernous malformations (ISCCMs) have been infrequently reported and considered exceptionally rare. To the best of our knowledge, Hadlich 26 provided the first published account of an ISCCM in 1903, and 9 years later, Schultze 57 reported the first successful total resection of an ISCCM in a 29-year-old man. In recent decades, the widespread availability of MRI has resulted in an apparent increase in the incidence of these lesions, although they remain uncommon. 51 A limited number of reviews have discussed the literature concerning ISCCMs. 7, 24, 73 Since then, several additional large series have been published. 1, 2, 6, 12, 17, 20, 27, 32, 34, 36, 37, 39, 42, 59, 62, 67 Because of the relative rarity of these lesions, information pertaining to clinical outcomes for patients harboring ISCCMs is scarce.
Our objective with this systematic review and metaanalysis was to provide a comprehensive appraisal of the published data concerning ISCCMs. We carefully and critically evaluated the epidemiological features of ISCCMs and, using individual patient data, examined the predictors of favorable neurological outcomes for patients who underwent operative or conservative (observation) treatment.
Methods
We undertook a systematic review and meta-analysis. Our methods were in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement 44 and the Meta-Analysis of Observational Studies in Epidemiology guidelines. 60 
Search Strategy
Two independent reviewers conducted a comprehensive electronic search for articles on ISCCMs. They searched MEDLINE (PubMed and Ovid), EMBASE, CINAHL, Google Scholar, and The Cochrane Library from the start date of each database through June 2013. Databases were queried by using key words and MeSH terms associated with the pathology (that is, cavernous malformation, cavernoma, cavernous h(a)emangioma, cavernous angioma, angiographically occult vascular malformation), cross-matched with terms pertinent to the CNS location (that is, intramedullary, spine, spinal cord) in various combinations. For all studies that the reviewers considered relevant, we obtained the full-text version.
To identify additional resources, we manually searched references of articles with potential relevance.
Study Selection
We selected articles reporting clinical outcomes for patients with surgically or conservatively treated ISCCMs.
We included only articles that documented, at a minimum, patient age, patient sex, and spinal level of cavernous malformation for eligible patients, either as individual patient data or pooled data. We excluded articles reporting fewer than 3 patients and articles in which the relationship of the cavernous malformation to the spinal cord (that is, extradural, intradural, extramedullary, or intramedullary) was not clear. In cases of multiple, overlapping series from the same institution published over time, to prevent duplication, we included only the most inclusive series. We excluded abstracts presented at conferences and letters to editors if studies were not published as full reports. We included studies not published in English if they presented information meeting the above selection criteria in a translated English abstract. Disagreements between the 2 reviewers about whether to include or exclude a study were resolved by discussion and consensus with a third reviewer.
Data Extraction
Two independent reviewers performed data extraction. Discrepancies were settled by discussion and consensus. Information was gathered from eligible articles (systematic review) and patient medical records (current series) by using data abstraction forms including the following: total number of patients, patient age, patient sex, spinal level of cavernous malformation, lesion size, presence of cerebral cavernous malformations, family history of cavernomatosis, clinical course, presenting symptoms, symptom duration, rate of hemorrhage, treatment strategy, follow-up, and long-term outcome. When possible, individual patient data were recorded.
Definition of Variables
Cavernous malformation size was reported as the maximum transverse diameter. Patients' clinical courses were classified according to the scheme proposed by Bian et al. 5 This system divides symptom evolution into either slowly progressive neurological deterioration or acute neurological decline followed by slow, stepwise deterioration with variable periods of clinical improvement. Symptoms were categorized as motor, sensory, pain, or bladder and/ or bowel. For patients who underwent conservative treatment, duration of clinical history was defined as the period from symptom onset to last follow-up. For patients who underwent surgery, duration of symptoms was defined as the time from onset of symptoms to surgery. Operative approaches were separated into 3 groups: posterior (hemilaminectomy, total laminectomy, or laminoplasty), ventral, and lateral. We classified spinal location of cavernous malformations as either superficial or deep/ventral. Among patients who underwent surgery, the division between superficial versus deep was based on intraoperative findings because MRI has shown poor accuracy for predicting whether an ISCCM abuts a pial surface. 65, 68 Deep ISCCMs were those lacking an exophytic component or those without a bulging appearance or bluish discoloration on the dorsal pial surface. Ventral lesions were those requiring a ventral or lateral surgical approach. We defined the extent of resection as either incomplete (that is, biopsy, partial, or subtotal) or gross total. The definition of hemorrhage was variable among the included studies (that is, clinical, radiological, or both). When calculating hemorrhage rates, for each study we considered hemorrhage as defined by the respective authors of included articles.
Our primary outcome measured was change in neurological function from the first presentation to long-term follow-up examination. Included articles described use of various methods to report outcomes, most commonly a simple scale of better, same, or worse. Several articles reported use of a standardized scoring tool for assessing neurological function, including the McCormick, 1, 12, 15, 17, 20, 30, 35, 37, 39, 40 Frankel, 5, 6, 8, 42, 53, 59, 73 American Spinal Injury Association impairment, 50 and Aminoff-Logue disability 36 scales. For each included study, we defined improved, unchanged, or worsened neurological function the same as that reported by the authors of eligible articles.
Quality Assessment
Two investigators performed quality assessment. For each eligible study, they used the Newcastle-Ottawa Scale 69 to evaluate comparability, selection of cohort, and assessment of outcomes.
Statistical Analyses
Data from all included studies, in addition to our single-center series, were used to evaluate the epidemiology, clinical features, and neurological outcomes for patients who underwent operative or conservative management for ISCCM (that is, descriptive analysis).
When individual patient data were available, we examined several factors as predictors of favorable neurological outcomes by using univariate and multivariate logistic regression analyses (that is, quantitative analysis). These factors included patient age (continuous variable), patient sex, lesion spinal level(s) involved (cervical, thoracic, and/or lumbar), lesion size (≤ 10 or > 10 mm), presence of concomitant intracerebral cavernous malformations, family history of cavernomatosis, clinical course (acute with stepwise progression or slowly progressive), presenting symptoms (motor, sensory, pain, and/or bladder/bowel), treatment strategy (surgery or conservative), duration of clinical history (≤ 5 or > 5 years) for patients who underwent conservative management, duration of symptoms before surgery (≤ 3 or > 3 months), surgical approach (hemilaminectomy, ventral/lateral, or total laminectomy/laminoplasty), lesion spinal location (superficial or deep/ventral), and extent of resection (gross total or incomplete). We calculated odds ratios (ORs) with 95% confidence intervals (CIs) and p values for all evaluated independent variables. A criterion for statistical significance was an alpha error of less than 0.05. SPSS Statistics version 20 (IBM) was used for regression analyses.
To calculate the pooled estimate of the annual hemorrhage rate for ISCCMs, we performed a meta-analysis. We investigated heterogeneity among studies by using the Q test and quantified by the I 2 statistic, which represents the percentage of total variation across studies with a predefined I 2 greater than 50% as the cutoff point of statistical heterogeneity. 
Results
Eligibility criteria were met by 39 articles, totaling 608 patients 1, 5, 6, 8, 9, 11, 12, 14, 15, 17, [20] [21] [22] [23] 27, 28, 30, [34] [35] [36] [37] [38] [39] [40] [41] [42] 45, 46, 49, 50, 53, 54, 58, 59, [62] [63] [64] 67, 73 (Fig. 1) , in addition to our institutional series of 24 patients with ISCCMs (total of 40 series and 632 patients). Individual patient data were available from 31 studies plus our institutional series (total of 32 series and 400 patients). 1, 5, 6, 8, 9, 11, 12, 14, 15, [20] [21] [22] [23] 27, 28, 30, 36, 37, 39, 41, 45, 46, 49, 50, 53, 54, 58, 59, 62, 63, 73 All reports were retrospective observational studies. The overall quality of eligible studies was high, defined by more than 4 points according to the Newcastle-Ottawa Scale. Descriptive epidemiological and clinical data from included articles are summarized in Table 1 .
Epidemiological and Clinical Features
The mean patient age was 39.1 years (range 2-80 years). The male-to-female ratio was 1.1:1. The spinal level of the cavernous malformation was cervical in 240 (38%) patients, cervicothoracic in 15 (2.4%), thoracic in 349 (55.2%), thoracolumbar in 4 (0.6%), lumbar in 13 (2.1%), and conus medullaris in 11 (1.7%). Average cavernous malformation size was 9.2 mm. Of 389 patients who underwent evaluation for concomitant intracranial lesions, 64 (16.5%) had 1 or more associated cerebral cavernous malformations. A family history of cavernous malformations was found for 26 (11.9%) of 219 assessed patients. The clinical course involved acute, stepwise neurological decline for 237 (45.4%) patients and slow, progressive neurological deterioration for 285 (54.6%). Of 559 patients with data pertaining to symptoms, motor symptoms occurred in 338 (60.5%), sensory symptoms in 323 (57.8%), pain in 189 (33.8%), bladder/bowel dysfunction in 132 (23.6%), and respiratory distress in 3 (0.5%); 5 (0.9%) patients were asymptomatic.
Clinical Outcomes
Rates of ISCCM hemorrhage reported in the literature ranged from 1.4% to 6.8% per year. 1, 5, 12, 30, 34, 37, 50, 53, 73 According to our meta-analysis, the calculated pooled estimate of the annual hemorrhage rate was 2.1% (95% CI 1.3%-3.3%) (Fig. 2) . Although the heterogeneity was high (I 2 = 89%), which can be explained by the variable definitions of hemorrhage among included studies, no publication bias was detected (Egger p = 0.78 and BeggMazumdar p = 0. 28) All patients reported in the included articles, except 1, underwent either surgical or conservative management ( Table 2) . For 1 patient, the cavernous malformation was found only during autopsy. 46 Univariate logistic regression analyses for predictors of favorable neurological outcome by use of individual patient data are detailed in Table 3 Table 4 for patients who underwent operative treatment, and Table 5 for patients who underwent conservative treatment. The results of multivariate analysis are reported in Table 6 . Durations of follow-up varied. Mean follow-up lengths for each study are reported in Table 2 .
Of the 631 patients who received treatment, 567 (89.9%) underwent operative resection of ISCCM. Gross-total resection was achieved for 441 (94.0%) of 469 patients. Early transient postoperative complications occurred at a rate of 27.2%. At follow-up, neurological function was better than it had been preoperatively for 264 (51.5%) patients, was the same for 194 (37.8%), and was worse for 55 (10.7%). According to univariate analysis, resection was significantly associated with favorable neurological outcome compared with conservative management (OR 2.79, 95% CI 1.46-5.33, p = 0.002). Resection of the lesion within 3 months of symptom onset correlated positively with a favorable neurological outcome (OR 2.11, 95% CI 1.31-3.41, p = 0.002). By contrast, a substantially larger proportion of patients who underwent later resection (> 3 months) had experienced decreased neurological function at follow-up (28 [13. 4%] of 209) than did those who underwent earlier surgery (≤ 3 months) (1 [0.9%] of 110). With regard to surgical approaches, hemilaminectomy was associated with better outcomes than total laminectomy or laminoplasty (OR 3.20, 95% CI 1.16-8.86, p = 0.03). According to this systematic review, rates of neurological improvement after surgical resection were no higher for patients with superficial cavernous malformations than for those with deep-seated or ventrally located lesions (OR 1.36, 95% CI 0.71-2.60, p = 0.36). Between these 2 groups, rates of neurological worsening were also comparable (12 [7. 4%] of 163 and 6 [12.2%] of 49, respectively). Gross-total versus incomplete resection (biopsy, partial, or subtotal) was a statistically significant predictor of good outcome (OR 3.61, 95% CI 1.24-10.52, p = 0.02).
Treatment was conservative management by observation for 64 (10.1%) patients. Neurological function at the time of follow-up compared with function at initial presentation was improved for 16 (30.2%) patients, unchanged for 31 (58.5%), and worse for (11.3%). According to univariate analysis, among patients who underwent conservative management, a clinical history of 5 years or less was associated with good outcome (OR 10.0, 95% CI 1.07-93.44, p = 0.04). Given the relatively smaller sample size and the resultant wide confidence interval, these results should be interpreted cautiously. In this systematic review, the following were not statistically significant prognostic factors: patient age, patient sex, spinal level(s) of lesion involvement, lesion size, presence of cerebral cavernous malformations, and family history of cavernomatosis. Better neurological function at follow-up was associated with acute/stepwise rather than slowly progressive clinical presentation. For the overall (operative and conservative) and operative groups, this difference was statistically significant (OR 1.72, 95% CI 1.10-2.68, p = 0.02) and (OR 1.62, 95% CI 1.01-2.60, p < 0.05), respectively. This trend was also observed among patients who underwent conservative treatment, although the trend was not statistically significant, possibly because of the relatively smaller sample size (OR 2.67, 95% CI 0.65-10.88, p = 0.17). The presence of motor symptoms correlated significantly with good functional outcome (OR 1.76, 95% CI 1.08-2.86, p = 0.02). By contrast, the presence of sensory symptoms was associated with poor neurological recovery (OR 0.58, 95% CI 0.35-0.98, p = 0.04).
To control for possible confounding, we performed a multivariate analysis that included patient age, clinical course, spinal location of lesion, duration of symptoms before surgery, and extent of resection. According to multivariate analysis, significant predictors of favorable neurological outcome were surgery within 3 months of symptom onset (OR 3.35, 95% CI 1.03-10.90, p = 0.04) and gross-total resection (OR 7.76, 95% CI 1.31-46.16, p = 0.02); factors that were not significant predictors were patient age, clinical course, and spinal location of lesion.
Discussion
The meta-analysis reported here is a careful and comprehensive appraisal of articles published over a period of more than 50 years. Although ISCCMS are rare, we found 40 articles, describing more than 600 patients.
According to the literature, patient age at the time of ISCCM diagnosis ranged from 2 to 88 years. 27, 71 Mean patient age at time of presentation was 39.1 years (late 30s/ early 40s). 7, 24, 47, 73 Early reviews noted a preponderance of ISCCMs among female patients (59%-69% of patients were women). 7, 47, 73 The literature then shifted toward a more balanced distribution, with no clear sex predilection. 24 However, taking into account more recent, sizeable series, 1, 20, 28, 30, 36, 37, 50, 62 we found a slight predominance of ISCCMs among male patients (male-to-female ratio 1.1:1). We confirmed a predilection of ISCCMs for thoracic, followed by cervical, spinal levels. 7, 24, 47, 73 We found the distribution of clinical course to be 45% acute/stepwise and 55% slowly progressive, in agreement with rates reported by Gross et al. (46% and 54%, respectively). 24 With regard to etiology, progressive neurological decline is thought to result from enlargement of the lesion, which may be caused by microhemorrhages, hyalinization of vascular channels, intraluminal thrombosis, microcirculatory changes, or capillary proliferation. 5, 47 By contrast, an acute, stepwise pattern of clinical evolution is probably caused by frank lesion hemorrhage into the spinal cord parenchyma. 5, 47 The distribution of symptoms found by our review was 60% motor, 58% sensory, 34% pain, and 24% disturbance of bladder and/or bowel function. Brain cavernous malformations coexisted in 16% of patients evaluated for intracranial lesions, and a family history was found for 12% of included patients. In the review conducted by Gross et al., 24 these rates were 27% and 9%, respectively. Mitha et al. 42 reported intracranial cavernous malformations for 17 (34%) of 50 patients with ISCCMs who underwent cranial MRI. Of these 17 patients, 5 (29%) had a known family history. In our current single-center series of ISCCMs, 50% of patients had 1 or more intracerebral cavernous malformations and 50% had a family history.
Because of the rarity of ISCCMs, data pertaining to predictors of outcome in patients harboring these lesions are scarce. Reports have suggested that presurgical symp- toms have prognostic significance. Cantore et al. 9 qualitatively observed poorer outcomes for patients with longer clinical histories. Zevgaridis et al. 73 found that preoperative symptom duration of fewer than 3 years was statistically significant for predicting a favorable outcome; however, other studies failed to replicate these findings.
35
Some series found greater severity of preoperative neurological impairment to be associated with unfavorable outcomes. 1, 7, 15 By contrast, patient age and sex have shown no correlation with outcomes. 7, 35, 73 Spinal cord cavernous malformations are managed with either surgical resection or observation. In our meta-analysis, most (90%) patients underwent resection and only 10% underwent conservative management, reflecting the general practice among neurosurgeons of resecting these lesions when patients are symptomatic. Our results provide statistical evidence supporting this management approach. The rates of improved, stable, and declined neurological function among patients who underwent conservative management were 30%, 58%, and 11%, respectively. In comparison, neurological outcomes were better among patients who underwent surgery (51% improved, 38% unchanged, and 11% worse). Among those who underwent nonsurgical treatment, outcomes were even less favorable for patients who were observed beyond 5 years from symptom onset. This finding supports the general understanding that the natural history of ISCCMs seems to be progressive deterioration over time with resulting poorer outcomes. In our systematic review, the calculated pooled rate for hemorrhage was 2.1% per year. These findings are essential for guiding clinical decision making regarding the management plan for patients with ISCCMs.
In 2011, Mitha et al. 43 published a technical report detailing 3 primary operative approaches to ISCCMs: posterior, posterolateral, and lateral. Of these, the poste- rior approach is the most commonly used, specifically for dorsal or central cavernous malformations. Intraoperative neurophysiological monitoring of somatosensory-evoked potentials and motor-evoked potentials is routinely performed during resection. A laminectomy or hemilaminectomy is performed over the appropriate spinal level, and the dura is opened. Often, the cavernous malformation can be localized on the basis of the appearance of the dorsal pial surface, which reveals an exophytic lesion, blue-purple discoloration, and/or bulging. In such cases, a myelotomy is made directly over the lesion. The traditional approach to deep-seated ISCCMs without sur- face abnormalities is midline myelotomy. 43 Good results have also been reported from use of various localization techniques to guide myelotomy, including intraoperative ultrasonography 5, 6 and indocyanine green videoangiography. 20 Other options for more ventral or lateral lesions include myelotomy through the dorsal root entry zone, 43 anterolateral partial vertebrectomy or corpectomy, 19, 45 and radical facetectomy and dentate ligament resection. 37 At the lesion site, a gliotic plane between the cavernous malformation and spinal cord usually facilitates removal. We found that the hemilaminectomy approach resulted in better outcomes for patients undergoing resection of spinal cavernous malformation compared with complete laminectomy or laminoplasty. This finding is probably attributable to the lesser iatrogenic spinal cord injury, milder postoperative reaction, and better spinal stabilization associated with minimally invasive microsurgical approaches. For these reasons, some authors have recently favored hemilaminectomy for resection of intraspinal lesions. 3, 5, 55, 61, 72 According to our review, the mean duration of preoperative symptoms was 29 months, substantially shorter than the 57-month average reported previously. 73 Furthermore, we found a statistically significant correlation between shorter duration of presurgical symptoms (≤ 3 months) and favorable clinical outcome. Hence, these findings support the practice of earlier resection, when surgery is indicated. Gross-total resection was achieved for 94% of patients. Rates of good, fair, and poor outcomes were 60%, 32%, 8% for patients for whom grosstotal resection was achieved; 29%, 47%, 24% for patients for whom resection was incomplete (biopsy, partial, or subtotal); and 32%, 55%, 13% for patients who underwent conservative management. These findings support a strategy of complete resection, if feasible, when an operative option is indicated. By contrast, patients who undergo surgery, but in whom total cavernous malformation resection is not achieved, might have less favorable outcomes than those who receive conservative management. For deep-seated or ventrally located lesions, a management strategy of close follow-up instead of operative resection has been proposed. 24 However, according to this systematic review, the location and depth of ISCCM were not statistically significant predictors of favorable outcomes.
Neurological recovery was better for patients whose clinical course was acute with stepwise progression rather than slowly progressive. To our knowledge, our study is the first to validate statistical significance for the classification scheme proposed by Bian et al. 5 in 2009, which is a modification of the system originally described by Ogilvy et al. in 1992. 47 In regard to patients' presenting signs and symptoms, motor abnormalities were correlated with more favorable clinical outcomes than were sensory symptoms. Sensory deficits have also been shown to be associated with slower and lesser recovery. 15, 21, 24, 50 This in-depth qualitative and quantitative analysis of the published literature on intramedullary spinal cord cavernous malformations goes back to the first case series reported on this rare neurosurgical condition more than 50 years ago. It also has limitations. First, all eligible reports, including our institutional experience, were based on retrospective observational study designs. By nature, retrospective studies are prone to data inaccuracy and missing information. This problem stems from the exceeding rarity of ISCCMs, which limits the ability to perform a prospective study and/or randomized trial. Another issue is confounding, which should be considered carefully when interpreting the findings of our logistic regression analyses. For example, cavernous malformations that were more superficial might have been selected for gross-total resection, whereas deep, inaccessible lesions might have been treated conservatively or might have been incompletely resected. Although we performed multivariate logistic regression analyses to control for confounding, we were unable to account for all potential confounders. However, perhaps the greatest limitation of our study was heterogeneity. Methods of included studies differed significantly. Among these differences were dissimilarities in assessment and definition of neurological outcomes (e.g., Frankel scale, McCormick scale, American Spinal Injury Association impairment scale), operative technique (e.g., dorsal midline myelotomy, intraoperative ultrasonography, indocyanine green videoangiography, anterior/lateral approach), and length of follow-up (e.g., 3 months, 6 months, 12 months). Moreover, our meta-analysis found statistical heterogeneity in annual hemorrhage rates, which was thought to be attributable to varying definitions of hemorrhage among included studies (that is, clinical, radiological, or both). Nonetheless, heterogeneity is inherent to systematic reviews and meta-analyses, given the inclusion of studies of varying populations, methods, and quality. In the context of an exceptionally rare disease such as ISCCM, the limitation of heterogeneity may be trumped by the strong statistical power of a meta-analysis, because individual studies might be too small (that is, underpowered) to discern important relationships. Therefore, with respect to ISCCMs, a comprehensive and well-conducted systematic review and meta-analysis, such as that reported here, might be considered the best available evidence, although not without limitation.
Conclusions
For symptomatic ISCCMs, our findings indicate favorable neurological outcomes for patients who undergo surgery relative to those who undergo clinical observation. However, our findings are limited by the relatively smaller number of patients reported in the literature who underwent conservative management. Prolonged observation of symptomatic lesions is likely to lead to progressive clinical decline with resulting poorer patient outcomes. The overall annual hemorrhage rate for ISCCMs is 2.1%. Early surgery, within 3 months of symptom onset, is associated with better outcomes. The goal of surgery, when indicated, should be complete resection. For dorsally or centrally located ISCCMs, a minimally invasive hemilaminectomy approach is preferred and is associated with superior neurological outcomes. Intraoperative imaging modalities, including ultrasonography and indocyanine green videoangiography, are described in the literature as useful adjuncts for localizing and resecting deep-seated cavernous malformations. In this systematic review, the depth and location of the lesion did not correlate with favorable postoperative neurological outcome. Moreover, cavernous malformation size and spinal level, as well as patient age and sex, were not significant prognostic factors. An acute, stepwise clinical course compared with a course of slow, progressive deterioration, and motor symptoms compared with sensory deficits, were associated with better functional outcomes.
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